ISRCTN52392534已完成未知
Efficacy of OROS-methylphenidate on specific executive functioning deficits in adults with Attention deficit hyperactivity disorder (ADHD)
Parnassia Bavo Academy (PBA) (Netherlands)0 个研究点目标入组 22 人开始时间: 2013年7月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
2014 results in https://www.ncbi.nlm.nih.gov/pubmed/24508533 (added 09/08/2019)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Between 18-55 years of age. The participants are of either sex. We included 22 adults with the combined subtype of ADHD, of which 17 were male and 5 were female.
- •2. Diagnosis of ADHD, combined subtype
排除标准
- •1. Having severe comorbid psychiatric disorders at time of the study screening (as measured by the Structured Clinical Interview for DSM disorders; SCID)
- •2. Receiving treatment with stimulants, antipsychotics, clonidine, benzodiazepines, or beta-blockers <1 month before study participation
- •3. Having any cognitive disorder like dementia or amnesic disorder
- •4. Mental retardation
- •5. Being pregnant or nursing
研究者
相似试验
已完成
3 期
An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity DisorderAttention Deficit Hyperactivity DisorderNCT00269776Alza Corporation, DE, USA
已完成
4 期
Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and MemoryAttention Deficit Hyperactivity DisorderNCT00530257Children's Hospital of Philadelphia30
已完成
3 期
A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity DisorderAttention Deficit Hyperactivity DisorderNCT00269802Alza Corporation, DE, USA
已完成
3 期
A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in ChildrenAttention Deficit Hyperactivity DisorderNCT00269789Alza Corporation, DE, USA
终止
3 期
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer PatientsFatigueGastrointestinal CancerBreast CancerNCT00516269M.D. Anderson Cancer Center42